A B S T R A C T Vitamin B12-deficient and normal rats were loaded with methylmalonic (MMA) and ethylmalonic acids labeled with`3C in the carboxyl groups and with 2H in the alkyl groups. Significant fractions of the administered acids were excreted in both the B12-deficient and the normal animal, having undergone exchange of both their "3C-labeled carboxyl groups with endogenous 12C. The exchange of the a-'H of MMA in 2H20 at 250C and pH 7.5 was found by 'H-nuclear magnetic resonance to have a half-life of 28.3 min.
INTRODUCTION
Methylmalonic acid (MMA)l is a metabolite derived in mammals from a wide variety of substrates, chiefly vaThis work is publication 83036 from the McGill UniversityMontreal Children's Hospital Research Institute.
Received for publication 23 March 1983 and in revised form 5 August 1983 . 1 Abbreviations used in this paper: B-CoA, butyryl CoA; CoA, coenzyme A; CoASH, free CoA; EMA, ethylmalonic line and isoleucine. There has been considerable controversy concerning the metabolism of valine. After incubating racemic [4,4-'4C2] valine with rat liver homogenate, Kinnory et al. (1) recovered labeled propionic, isobutyric, and 3-hydroxyisobutyric acids. To explain the presence of labeled propionate, they suggested that methylmalonyl semialdehyde (MMSA) was first decarboxylated to propionaldehyde, which, in turn, was oxidized to propionic acid. Robinson and co-workers (2) found that 3-hydroxyisobutyryl-coenzyme A (CoA), the precursor of MMSA, must be deacylated to the free acid before oxidation to MMSA; they proposed further that direct oxidation of MMSA to methylmalonyl-CoA (MM-CoA) followed by decarboxylation would also yield propionyl-CoA (P-CoA), implying that reversal of the P-CoA carboxylase reaction would be the final step in valine metabolism. Lane and Halenz (3) demonstrated the reversible nature of P-CoA carboxylase with MM-CoA, and also showed that ethylmalonyl-CoA and butyryl-CoA (B-CoA) are similarly interconvertible. In the MMA system, Retey and Lynen (4) showed that the MM-CoA produced by the action of P-CoA carboxylase has the S configuration. Tanaka and colleagues (5) have more recently demonstrated that P-CoA is an obligate intermediate between MMSA and S-MM-CoA. Scheme 1 summarizes the conversion of propionate to succinate as it is now generally accepted for mammals. To determine the extent to which S-MM-CoA is decarboxylated, we synthesized ethylmalonic acid (EMA) and MMA having "3C-labeled carboxyl groups Furthermore, incorporation of five 2H atoms into the ethyl moiety provides a separation of fragment ions derived from the endogenous and exogenous EMA that is 2 amu greater than that in the MMA study.
We demonstrate that exogenous MMA and-EMA excreted by the loaded rats have undergone partial decarboxylative exchange of '3C label in the carboxyl groups for endogenous 12C, presumably by the action of P-CoA carboxylase on the corresponding CoA esters. More significantly, we also demonstrate that the 13C label in the CoA ester function is similarly subject to depletion. This last finding indicates that a portion of the flow through the propionyl-to succinyl-CoA pathway passes through a free MMA intermediate. The currently accepted pathway includes only the CoAesterified derivatives of these acids.
The significance of these findings lie in an interpretation of the Mendelian phenotype known as methylmalonic aciduria (MMAuria). Over 100 cases of MMAuria have been reported. Of these, only one might be attributable to an error of MM CoA racemase; that patient has since been shown to have mutase deficiency (7, 8) . Our results suggest that putative racemase deficiency need not be associated with symptomatic MMAuria, because a free MMA shunt may allow a nonracemase-mediated conversion of S-MM-CoA to R-MM-CoA. (20 ml) in the manner of a standard malonate ester synthesis (10 (12) . The extracts were derivatized with 0.1 ml of TRI-SIL/BSA and were analyzed on the Hewlett-Packard 5984A with a 2-m column containing a 1:1 column-packing mixture of 4% Dexsil 300 and 6% OV-17 on Chromosorb W HP operated isothermally at 1 10C. This particular composition of column packing was required for the separation of MMA from 2-ethyl-3-hydroxybutyric acid, which is not separated by more conventional packings. MMA has a retention time of 4.4 min under these conditions. The M+ -CH' ions for MMA were monitored at m/z 252, 251, 250, and 247, corresponding to the deuterium-labeled '3C2, '3C1, and '3CO, and endogenous MMA species, respectively. All peak areas were corrected for isotopic impurities and natural isotopic abundances. Total MMA was measured relative to capric acid on the LKB 9000 in a similar mixed column.
METHODS

Materials
[2H5]-[13C2]EMA administration. The B%2-deficient rat Exchange of the methylmalonyl-a-'H for 2H in deuterium oxide at physiological pH. A buffer solution pH 8.0 was made from 0.68 g KH2PO4, 0.20 g NaOH, and deuterium oxide (final vol, 2.0 ml). To this was added 0.28 g sodium hydrogen methylmalonate with rapid dissolution by shaking. The time of this final mixing was noted and an aliquot was pipetted into a standard nuclear magnetic resonance (NMR) tube. 'H-NMR spectra were obtained on a Varian T-60A spectrometer over the next 70 min (Varian Associates, Inc., Palo Alto, CA). In all, 17 scans were taken with integration of the portion of the spectrum that included the resonances for the three methyl protons and the a-proton. The sample was mixed and was maintained at 25°C throughout the experiment. The pH of the mixture did not change over the 70 min (pH 7.5).
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RESULTS
Mass spectra of labeled synthesized acids
Mass spectra of TMS derivatives of the labeled acids synthesized for this study are shown in Fig. 1 tively, endogenous MMA, the unchanged administered substrate, and the administered substrate that has undergone exchange of one and both "C-labeled carboxyl groups. It may be seen that the unchanged administered loads were largely excreted within 24 h by all four rats. Significant amounts of MMA derived from the load (identified by the residual 2H3 label) that had been depleted of one or both 13C labels in the carboxyl groups were coexcreted. For rats 1, 2, and 4, the rate of ex-
]MMA did not slow as quickly as the excretion rate for the unchanged acid in going from the first to the second collection periods. This apparent delay in excretion for the former acid may relate to labeled MMA that is accumulated by mitochondria. In rat 4, endogenous MMA in the first two urine samples after the load was a small negative quantity after being corrected for unlabeled MMA in the labeled acid load. This finding may reflect preferential metabolism of unlabeled acid over labeled acid. A large primary kinetic isotope effect is known for this enzyme/substrate combination (13 Determined as amount excreted per kilogram of body weight during collection period, divided by period length.
t During whole collection period, 0-48 h (nmol/kg). § Rat did not urinate during this period.
After correction for isotopic purity, a small negative value was residual.
tensity, this ion also demonstrated the exchange of two 3C-labeled carboxyl groups. The B,2-deficient rat was given labeled EMA (by the gastric route) to determine whether an acquired reduction of MM-CoA mutase activity would further retard metabolic outflow of labeled substrate to the Krebs cycle and permit additional enhancement of EMA carboxyl exchange. B12 depletion was confirmed by measurement of serum B12 level (undetectable, <20 pg/ ml) and in the urinary MMA level (>500 mg/g creatinine). Relative to the control rat that was offered the same load by the same route, the B,2-deficient rat had elevated excretion rates for all three labeled EMA species. Although two control rats offered larger loads had comparable total excretion of acids depleted in 13C, the rat given the load by intraperitoneal injection had a higher initial rate of excretion of the administered acid than the rat given the load by gastric tube.
Determination by NMR of the rate of exchange of the a-hydrogen of MMA for 2H in 2H20 at pH 7.5 and 250C. Over the period of 70 min, the doublet for the three methyl protons was transformed gradually into a singlet without significant change in the overall integrated intensity. On the other hand, the integrated quartet signal due to the a-proton experienced gradual decay. Fig. 2 illustrates the first-order decay of the aproton signal (normalized to the invariant methyl proton signal). The half-life for exchange was 28.3 min.
DISCUSSION
Our observation of the replacement of '3C by 12C in one of the carboxyl groups of MMA (Table I) , when § During whole collection period, 0-48 h (nmol/kg). 11 Estimation because of interference of broad defocused skirt of intense m/z 268 produced by administered acid.
MMA was originally labeled with "3C in both carboxyl groups, supports the view now generally held that S-MM-CoA achieves P-CoA carboxylase-mediated equilibrium of the free carboxyl group with endogenous CO. We further show that the carboxyl group esterified to CoA is also subject to decarboxylative exchange with endogenous CO2. The known pathway of MMA metabolism however fails either to predict or allow for this last exchange (Scheme 1). We also present evidence that EMA will undergo analogous exchange during its own metabolism (Table II) .
P-CoA carboxylase and acetyl-CoA carboxylase are reversible enzymes (15, 16) , and both can carboxylate P-CoA and B-CoA (17, 18) . Waite (Fig. 3) , the interconversion of the free R and S-1-['3C]MMA, is rapid compared with the overall rate of MMA metabolism. The first assumption is supported by our observation of metabolic loss of label from the administered malonic acids: some of the load must have been esterified and then metabolized as the CoA derivative. Further support is provided by the observation of the massive excretion of free MMA seen in methylmalonic acidemia. If MMA remained irreversibly bound to CoA, in this disorder, one would further expect to see a urinary glycine conjugate of MMA produced by the hepatic enzyme, glycine-N-acylase from the accumulating R-MM-CoA. Glycine conjugation appears to be an important detoxification mechanism in several inborn errors of metabolism, such as isovaleric acidemia (19) , but not in methylmalonic acidemia.
The differences reported between the ratios of liver CoA intermediates of propionate metabolism and the corresponding urinary free acids (20) can be interpreted to demonstrate the relative ease of deacylation of MMCoA. In B12-deficient rats that had elevated P-CoA and MM-CoA in liver, the ratio of P-CoA to MM-CoA was 1.8. In control rats, this ratio was -1.0. However, the urinary free acids in B12-deficient rats poorly reflect this ratio; excretion of MMA was much higher relative to propionic acid. The corresponding urinary pattern is seen in humans with methylmalonic acidemia. It is, therefore, likely that deacylation of MM-CoA is more efficient than that of P-CoA and serves as a means for elimination of MMA while sparing CoA. Deacylation to free MMA has been demonstrated in homogenates of liver, kidney, and brain in both control and B12-deficient rats (21 (22), it would appear that there is ample opportunity for the spontaneous racemization of free MMA bearing one remaining carboxyl label. Reesterification could therefore occur on either of the labeled or unlabeled carboxyl groups with roughly equal probability, thereby exposing the remaining label in the S-MM-CoA enantiomer to decarboxylative loss by P-CoA carboxylase (as proposed in Fig. 3) .
The loadings of labeled EMA, summarized in Table  II, (Fig. 3, reactions B and C, respectively) followed by reesterification to Coa may occur more rapidly than the excretion of free MMA. One possible explanation for this result is that nascent MMA and CoASH are maintained in close association with the acylase enzyme, so that escape of MMA into free solution is slow compared with the effective rate of carboxyl exchange of the reesterified S-MM-CoA by P-CoA carboxylase. When both labeled carboxyl groups have been lost, further equilibration with endogenous '2CO2 apparently continues; but ultimately some free MMA will be excreted, retaining its distinguishing [2Hj]methyl label which is refractory to exchange. Since MMA is excreted very efficiently (23), probably little of its load and, by analogy, little of EMA also succeeds in crossing into the mitochondria before excretion.
Whereas we believe our observation of exchange of the carboxyl group bound to CoA in MM-CoA is without precedent, other workers have published related.studies with labeled substrates that support this proposal. Baretz and Tanaka (24) examined urinary metabolites from rats after administration of various stable isotope-labeled isobutyrates. After feeding control and B,2/folatedeficient rats [3,3-'3C2] isobutyric acid, they analyzed urinary MMA for '5C content. The conventional pathway established by them suggests that this acid should be metabolized through MMSA and P-CoA to S-MMCoA. P-CoA should be obtained with both '`C labels intact as shown in Scheme 2.
significant that their B,2/folate-deficient rat exhibited greater loss of '8C than did the control. The deficient rat has a reduced rate of outflow from the MM-CoA pool, which would permit greater opportunity for multiple CoA transesterifications and P-CoA carboxylasemediated decarboxylations. Baretz et al. (25) investigated the metabolism of labeled 2-methylbutyric and butyric acids via the Rpathway (11) in rats to examine the relationship between ethylmalonyl semialdehyde and EMA. After [1-'5C]butyrate administration, excreted EMA had less label per mole than coexcreted N-butyrylglycine. Metabolic loss of the '5C carboxyl label in [1-'5C]butyrylCoA was discounted; the discrepancy could represent EMA produced from other unrelated sources, or from labeled precursor through exchange of the labeled carboxyl in B-CoA with endogenous 12CO2 by a mechanism homologous to that depicted in Fig. 3 .
We propose that reversible deacylation-reacylation of MM-CoA may function as a free MMA shunt operating in parallel with MM-CoA racemase (Scheme 3). In other words, hydrolysis of S-MM-CoA followed 13CH3 13CHO 13COSCoA 13COSCoA
Carboxylation of P-CoA should therefore yield MMCoA with the same 13C content as the starting acid (80% '3C2, 18% '3Cl, and 2% '3CO). The MMA from a normal rat after the load was reported to be 35% 13C2, 12% I'C,, and 53% "5Co. (26) demonstrated that S-MM-CoA produced by crystalline P-CoA decarboxylase from PCoA could be slowly racemized; aliquots of the preparation of increasing age were found to give larger yields of succinyl-CoA on treatment with purified mutase. They also studied enzyme dependence for conversion of a mixture of 1-and 4-["4C]succinyl-CoA to P-CoA and '4CO2 in the presence of mutase, racemase, and P-CoA carboxylase (26) . Even in the absence of racemase, some "CO2 was liberated, possibly through spontaneous racemization of S-MM-CoA. The authors concluded further that there was no intermolecular exchange of CoA between "C-labeled MMA and unlabeled racemic MM-CoA in their in vitro system, and thus dismissed this as a mechanism for racemizing S-MM-CoA. However, an acylase that is not present in the purified in vitro preparation might achieve a nonracemase-mediated racemization in vivo.
Overath et al. (27) showed that 89% of the succinylCoA formed from racemic MM-CoA in the presence of hepatic racemase and mutase incorporated 3H-labeling from 3H20 added to the incubation mixture, and 1% was labeled when the racemase was absent. This slow incorporation of 3H into succinyl-CoA in the absence of racemase also suggests that MM-CoA can spontaneously racemize, presumably through an enolic intermediate. They further showed that the model compound, S-methylmalonyl-N-succinyl, cysteamine, spontaneously exchanges the a-proton for deuterium at pH 7.5 These results are also consistent with a deacylase-mediated inter-or intramolecular transfer of CoA to the other carboxyl group that may operate in vivo as a racemizing mechanism for MM-CoA. Racemase-independent racemization could occur by two mechanisms: option I, deacylase-mediated hydrolysis to the free acid and CoASH, followed by random reesterification with CoASH to either carboxyl group; option II, enolization of MM-CoA and consequent loss of chirality.
Accordingly, we propose that the propionate pathway for conversion to succinate is accommodated by both spontaneous racemization and the appearance of free all times R-MM-CoA can be converted by the mutase reaction D to succinyl-CoA and lost to the Krebs cycle. As can be seen, this mechanism provides a nonracemase-mediated path for racemization of MM-CoA. Not represented here for the sake of clarity is spontaneous racemization which can slowly interconvert R and S-MM-CoA (e.g., 2 The hydrolytic mechanism will spare CoA and facilitate excretion of large amounts of free MMA in the mutasedeficient phenotype and EMA in the case of multiple dehydrogenase defects. This mechanism is important in this last disorder, because EM-CoA is not the preferred substrate for a competent mutase enzyme (6) .
Finally, we must ask whether both these mechanisms are sufficient to offset a hypothetical racemase deficiency in vivo.
Only one case of racemase defect has been reported (7) . Subsequent studies of fibroblast enzymes from this patient confirmed mutase apoenzyme deficiency instead of racemase deficiency (8) . More than 100 patients have been reported with isolated methylmalonic acidemia; none has had a racemase defect. There are various interpretations for the preponderance of mutase-deficient MMAuria: (a) racemase deficiency is a lethal defect in the fetus; (b) it is a benign disorder that escapes detection because of the free MMA shunt; (c) mutations do not occur at a racemase locus; (d) there is no racemase locus. The first and third proposals await evidence; the fourth seems unlikely because of evidence for a racemase protein (26) ; the second is favored by our findings reported here.
